fda - Search News

FDA upgrades recalled broccoli to highest level

HuffPost on MSN · 3h

FDA Assigns Highest Risk Level To These Recalled Chocolate Snacks

The snacks are now part of a Class I recall, which is for products with the potential of "serious adverse health consequences." Here's what to know.

Houston Chronicle on MSN · 7h

FDA upgrades recalled broccoli to highest level over possible Listeria contamination

The U.S. Food and Drug Administration upgraded the classification of recalled broccoli sold at Walmart originally issued in December to its highest recall category, according to the agency’s updated report.

Broccoli recall: FDA upgrades recall to ‘deadliest level’ for florets sold at Walmart in 20 states, throw out ASAP

The recall announced in January involves contaminated broccoli sold in 20 states. Here's everything you need to know

Acrivon Therapeutics, FDA and Breakthrough Device

Business Insider · 16h

Acrivon Therapeutics:FDA Grants Breakthrough Device Designation For ACR-368 OncoSignature Assay

Wednesday, announced that the FDA has granted Breakthrough Device designation for the ACR-368 OncoSignature assay for the treatment of endometrial cancer. The ACR-368-tailored OncoSignature assay is being used to identify patients most likely to respond to the company's lead drug candidate ACR-368 in an ongoing,

MarketWatch · 19h

Acrivon Therapeutics Gets FDA Breakthrough Device Designation for Cancer Identification

Acrivon Therapeutics said the Food and Drug Administration has granted Breakthrough Device designation for its ACR-368 OncoSignature assay, an immunofluorescence assay for the identification of endometrial cancer patients who may benefit from ACR-368 treatment.

Investing.com on MSN · 17h

ACR-368 OncoSignature assay gains FDA breakthrough status

Acrivon Therapeutics, Inc. (NASDAQ: ACRV), a clinical stage biopharmaceutical company with a market capitalization of $184 million and an impressive 60% stock return over the past year, announced that its ACR-368 OncoSignature assay has received Breakthrough Device designation from the U.

1don MSN

FDA Changes Raise Concerns About Food Recalls

The number of hospitalizations and deaths from foodborne illness doubled last year compared to 2023 in the U.S.

1d

FDA is recalling more than 32,000 packages of these popular breadcrumbs sold nationwide

The California-based company has recalled 26,400 eight-ounce packages of its Unseasoned Bread Crumbs (Pan Rayado) and 6,240 ...

2don MSN

FDA approves pig organ transplant trials for patients with kidney failure

The first clinical trials using organs from genetically modified pigs offer hope to patients with kidney failure, who face a ...

1d

FDA Approves Clinical Trials for Pig Kidney Transplants in Humans

TUESDAY, Feb. 4, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved the first-ever clinical ...

FDA-Approved Calquence Combo Is First and Only of Its Kind in MCL

Dr. Tycel Phillips discusses the FDA approval of a Calquence combo in MCL, making it the first and only BTK inhibitor ...

6don MSN

FDA approves first new type of pain medication in 25 years

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

Interesting Engineering on MSN21h

US FDA approves first-ever smart glasses with hearing aid for mild to moderate loss

EssilorLuxottica's Nuance Audio Glasses receive FDA clearance for OTC sales in the US, revolutionizing hearing solutions with ...

Targeted Oncology13h

FDA Expands PATHWAY HER2 (4B5) Test to Include HER2-Ultralow Status

The PATHWAY HER2 (4B5) test is now FDA-approved to assess HER2-ultralow status in metastatic breast cancer, expanding its ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results